Elevation of serum adiponectin and CD146 levels in diabetic nephropathy

Diabetes Research and Clinical Practice

Volumn 78, Issue 1, 2007, Pages 85-92

  Saito, Takako ^a   Saito, Osamu ^a   Kawano, Takahisa ^a   Tamemoto, Hiroyuki ^a   Kusano, Eiji ^a   Kawakami, Masanobu ^a   Ishikawa, San e ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Adiponectin; CD146; Diabetic nephropathy; Vascular disease

Indexed keywords

ADIPONECTIN; CD146 ANTIGEN; CREATININE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD146; BLOOD GLUCOSE; CREATININE; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES;

EID: 34548309401     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.02.014     Document Type: Article

References (22)

1. Ross R. Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 40 (1999) 115-126
2. Libby R., Ridker R.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
3. Scherer R.E., Williams S., Fogliano M., Baldini G., and Lodish H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270 (1995) 26746-26749
4. Maeda K., Okubo K., Shimomura I., Funahashi T., Matsuzawa Y., and Matsubara K. cDNA cloning and expression of a novel adipose collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochem. Biophys. Res. Commun. 221 (1996) 286-289
5. Okamoto Y., Arita Y., Nishida M., Muraguchi M., Ouchi N., Takahashi M., et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm. Metab. Res. 32 (2000) 47-50
6. Ouchi N., Kihara S., Arita Y., Okamoto Y., Maeda K., Kuriyama H., et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kB signaling through a cAMP-dependent pathway. Circulation 102 (2000) 1296-1301
7. Yokota T., Oritani K., Takahashi I., Ishikawa J., Matsuyama A., Ouchi N., et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96 (2000) 1723-1732
8. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103 (2001) 1057-1063
9. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., et al. Novel modulator for endothelial adhesion molecule: adipocyte-derived plasma protein adiponectin. Circulation 100 (1999) 2473-2476
10. Arita Y., Kihara S., Okamoto Y., Ouchi N., Takahashi M., Maeda K., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257 (1999) 79-83
11. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., et al. Plasma concentrations of a novel, adipose-specific protein adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1595-1599
12. Kumada M., Kihara S., Sumitsuji S., Kawamoto T., Matsumoto S., Ouchi N., et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 85-89
13. Pichon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B., and Rimm E.B. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291 (2004) 1730-1737
14. Kawano T., Saito T., Yasu T., Saito T., Nakamura T., Namai K., et al. Close association of hypoadiponectinemia with arteriosclerosis obliterans and ischemic heart disease. Metabolism 54 (2005) 653-656
15. Zoccali C., Mallamaci R., Tripepi G., Benedetto R.A., Cutrupi S., Parlongo S., et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J. Am. Soc. Nephrol. 13 (2002) 134-141
16. Malyszko J., Malyszko J.S., Brzosko S., Wolczynski S., and Mysliwiec M. Adiponectin is related to CD146, a novel marker of endothelial cell activation/injury in chronic renal failure and peritoneally dialyzed patients. J. Clin. Endocrinol. Metab. 89 (2004) 4620-4627
17. The research committee of diabetic nephropathy: the renewal of classification by Research Committee of the Japanese Ministry of Health, Labor and Welfare for Disorders of diabetes mellitus. J. Jpn. Diab. Soc. 44 (2001) 623.
18. Looker H.C., Krakoff J., Funahashi T., Matsuzawa Y., Tanaka S., Nelson R.G., et al. Adiponectin concentration are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes. J. Clin. Endocrinol. Metab. 89 (2004) 4010-4017
19. Koshimura J., Fujita H., Narita T., Shimotomai T., Hosoba M., Yoshioka N., et al. Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy. Biochem. Biophys. Res. Commun. 316 (2004) 165-169
20. Chudek J., Adamczak M., Karkoszka H., Budzinski G., Ignacy W., Funahashi T., et al. Plasma adiponectin concentration before and after successful kidney transplantation. Transplant. Proc. 35 (2003) 2186-2189
21. Bardin N., Anfosso F., Masse J.M., Cramer E., Sabatier F., Le Bivic A., et al. Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion. Blood 98 (2001) 3677-3684
22. Bardin N., Moal V., Anfosso F., Daniel L., Brunet P., Sampol J., et al. Soluble CD146, a novel endothelial junctional marker, is increased in physiological setting linked to endothelial junctional alteration. Thromb. Haemost. 90 (2003) 915-920